Principal Financial Group’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $719K | Buy |
153,937
+40,191
| +35% | +$188K | ﹤0.01% | 1938 |
|
|
2025
Q1 | $624K | Buy |
113,746
+529
| +0.5% | +$2.9K | ﹤0.01% | 1903 |
|
|
2024
Q4 | $384K | Buy |
113,217
+10,748
| +10% | +$36.4K | ﹤0.01% | 2000 |
|
|
2024
Q3 | $292K | Buy |
102,469
+23,843
| +30% | +$68K | ﹤0.01% | 2029 |
|
|
2024
Q2 | $177K | Sell |
78,626
-10,992
| -12% | -$24.7K | ﹤0.01% | 2157 |
|
|
2024
Q1 | $198K | Buy |
89,618
+44,893
| +100% | +$99.2K | ﹤0.01% | 2182 |
|
|
2023
Q4 | $105K | Buy |
44,725
+1,601
| +4% | +$3.76K | ﹤0.01% | 2269 |
|
|
2023
Q3 | $80.2K | Sell |
43,124
-2,166
| -5% | -$4.03K | ﹤0.01% | 2311 |
|
|
2023
Q2 | $119K | Buy |
45,290
+30,325
| +203% | +$79.5K | ﹤0.01% | 2266 |
|
|
2023
Q1 | $24.4K | Sell |
14,965
-1,029
| -6% | -$1.68K | ﹤0.01% | 2413 |
|
|
2022
Q4 | $21.3K | Sell |
15,994
-70,054
| -81% | -$93.2K | ﹤0.01% | 2398 |
|
|
2022
Q3 | $134K | Sell |
86,048
-90,079
| -51% | -$140K | ﹤0.01% | 2275 |
|
|
2022
Q2 | $271K | Buy |
+176,127
| New | +$271K | ﹤0.01% | 2211 |
|
|
2021
Q4 | – | Sell |
-11,801
| Closed | -$29K | – | 2656 |
|
|
2021
Q3 | $29K | Sell |
11,801
-1,915
| -14% | -$4.71K | ﹤0.01% | 2559 |
|
|
2021
Q2 | $56K | Buy |
+13,716
| New | +$56K | ﹤0.01% | 2566 |
|
|
2021
Q1 | – | Sell |
-11,344
| Closed | -$56K | – | 2507 |
|
|
2020
Q4 | $56K | Buy |
+11,344
| New | +$56K | ﹤0.01% | 2389 |
|